Valuation : IOL Chemicals and Pharmaceuticals Limited

Market Cap 62.54B 661M 569M 535M 488M 913M 916M 6.34B 2.45B 32.02B 2.48B 2.43B 102B P/E 2027 *
28.4x
P/E 2028 * 22x
Enterprise Value 62.54B 661M 569M 535M 488M 913M 916M 6.34B 2.45B 32.02B 2.48B 2.43B 102B EV / Sales 2027 *
2.28x
EV / Sales 2028 * 1.98x
Free-Float
33.91%
Yield 2027 *
-
Yield 2028 * -
1 day+6.50%
1 week+9.37%
Current month+9.93%
1 month+30.59%
3 months+61.95%
6 months+187.67%
Current year+159.03%
1 week 186
Extreme 186
217.4
1 month 155.15
Extreme 155.15
217.4
Current year 67.14
Extreme 67.14
217.4
1 year 67.14
Extreme 67.14
217.4
3 years 57.51
Extreme 57.51
217.4
5 years 54.44
Extreme 54.44
217.4
10 years 8.4
Extreme 8.4
217.4
Manager TitleAgeSince
Chief Executive Officer 34 -
Director of Finance/CFO - -
Compliance Officer - 14/11/2019
Director TitleAgeSince
Chairman 63 01/09/2007
Director/Board Member 34 29/05/2015
Chairman 73 -
Change 5-day change 1-year change 3-year change Capi.($)
+6.50%+9.37%+119.80%+140.19% 622M
-0.88%-2.15%+58.05%+105.26% 1,024B
-1.15%+2.68%+54.25%+74.19% 663B
-1.44%+0.38%+20.65%+76.13% 453B
-0.95%+0.23%+30.91%+37.78% 352B
-3.18%+1.78%+22.62%+41.55% 304B
+0.30%+0.67%+0.60%+11.25% 252B
-1.55%+1.11%+54.15%+75.59% 236B
+0.02%+2.24%-13.83%-55.80% 206B
-0.15%+3.65%+31.24%+103.39% 187B
Average -0.23%+1.41%+37.84%+60.95% 367.9B
Weighted average by Cap. -1.04%+0.62%+37.68%+66.91%

Financials

2027 *2028 *
Net sales 27.42B 290M 249M 235M 214M 400M 402M 2.78B 1.07B 14.04B 1.09B 1.07B 44.73B 31.52B 333M 287M 270M 246M 460M 462M 3.2B 1.24B 16.14B 1.25B 1.22B 51.42B
Net income 2.2B 23.24M 19.99M 18.8M 17.16M 32.09M 32.2M 223M 86.16M 1.13B 87.28M 85.37M 3.59B 2.84B 30.03M 25.83M 24.29M 22.17M 41.47M 41.6M 288M 111M 1.45B 113M 110M 4.63B
Net Debt - -
Logo IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) including Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Losartan Potassium, Levetiracetam, and Fenofibrate (Micronised). Its Specialty Chemical division includes Ethyl Acetate, Iso Butyl Benzene, Mono Chloro acetic Acid, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and the paint industry.
Employees
3,095
Date Price Change Volume
07/09/26 213.05 +6.50% 709,437
04/09/26 ₹200.05 +2.07% 345,178
03/09/26 ₹196.00 +4.09% 458,611
02/09/26 ₹188.30 -1.13% 183,596
01/09/26 ₹190.45 -1.73% 322,103
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
213.05INR
Average target price
197.00INR
Spread / Average Target
-7.53%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IOLCP Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!